Retirees are feeling the pinch of soaring healthcare costs and rampant inflation, with a particular concern being the skyrocketing prices of Medicare Part D drugs. A recent report from the AARP sheds light on this alarming issue, revealing that the list prices for the 25 brand-name drugs that accounted for the highest total Medicare Part D spending in 2021 have surged by a staggering 226% on average since their introduction to the market. Even more concerning is that some medications relied upon by over 10 million Medicare Part D enrollees have seen their prices more than triple. This has translated into price hikes ranging from 20% to a jaw-dropping 739%, affecting approximately 37% of total Medicare Part D spending, totaling $80.9 billion in 2021 alone.
Rising Costs: A Grim Reality
The AARP report exposes the harsh reality that these drug prices have consistently outpaced the annual rate of inflation since their market debut. For example, Enbrel, a medication vital in treating rheumatoid arthritis and psoriatic arthritis, has witnessed an astonishing 701% increase in price since its release in 1998, dwarfing the mere 85% general inflation rate over the same period. Similarly, the cost of Eliquis, a crucial drug for preventing and treating certain types of blood clots, has surged by 124%, compared to a modest 31% increase in the general inflation rate since its introduction.
Leigh Purvis, the prescription drug policy principal at the AARP Public Policy Institute, expressed concern over this trend, stating, “Brand-name drug prices have increased dramatically faster than inflation for decades. The median price of a new brand-name prescription drug is now approximately $200,000 per year, so even relatively small percentage price increases can translate into thousands of dollars and put life-saving medications out of reach of the patients who need them.”
Relief on the Horizon
Amidst this healthcare crisis, a glimmer of hope emerges with the Inflation Reduction Act of 2022. This legislation is designed to make Medicare coverage more affordable by empowering Medicare to negotiate lower prescription drug costs with participating private health insurance companies. Furthermore, the act sets forth provisions to cap out-of-pocket spending and limit increases in Medicare Part D premiums.
Some of the key highlights of the Inflation Reduction Act include measures aimed at providing relief to millions of seniors. However, it’s important to note that certain provisions will take effect as late as 2026, while others will roll out in 2023.
Nancy LeaMond, AARP’s executive vice president and chief advocacy and engagement officer, hailed the Inflation Reduction Act as a historic step in the right direction. She asserted, “This historic law cracks down on the big drug companies and brings real relief to millions of seniors who have been struggling with out-of-control prescription drug prices. American families simply can’t afford to keep paying the highest prices in the world for the medications they need.”
The Retirement Dilemma
As if rising healthcare costs and exorbitant drug prices weren’t enough, retirees are facing another dilemma – doubts about the reliability of Social Security benefits. A recent survey conducted by the Allianz Life Insurance Company of North America revealed that a staggering 74% of Americans no longer see Social Security benefits as a dependable source of income during retirement planning. An even more significant 88% of respondents emphasized the critical need for an alternative source of guaranteed income to retire comfortably.
Kelly LaVigne, the vice president of consumer insights at Allianz Life, stressed the importance of diversifying retirement strategies: “Social Security benefits are often the backbone of a retirement strategy, but it cannot be your entire strategy. A strong retirement strategy will ensure you have enough guaranteed income to cover your essential expenses. That guaranteed income can come from Social Security benefits along with other investments and protection products such as annuities.”
These survey findings arrive alongside projections that Social Security funds may deplete faster than anticipated, adding more uncertainty to retirees’ financial futures.
Finding Financial Stability
In these uncertain times, retirees and those nearing retirement age may find solace in exploring financial options that offer stability. One such avenue could be using a personal loan to pay off high-interest debt, thereby reducing monthly financial burdens. To discover your personalized interest rate without affecting your credit score, a visit to Credible may be a wise step.
In conclusion, the healthcare and retirement landscape for retirees is evolving rapidly. Skyrocketing drug prices and doubts about Social Security benefits are causing anxiety for many. However, legislative efforts like the Inflation Reduction Act aim to provide relief, and financial strategies such as personal loans can offer stability in these turbulent times. As retirees navigate these challenges, informed decisions and careful planning are crucial to ensure a comfortable and secure retirement.
Download our app MadbuMax on the Apple App Store for the latest news and financial tools. Interested in getting your finances in order do not forget to check Dr. Paul Etienne’s best-seller book on personal finance. To access more resources, tools, and services please click here. Also, do not forget to follow Dr. Etienne on IG or Twitter.